Nova Millennium Pharma India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.52 M
- Company Age 25 Year, 2 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 0.65 M
- Satisfied Charges ₹ 0.50 M
About Nova Millennium Pharma India
Nova Millennium Pharma India Private Limited (NMPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 December 1999 and has a history of 25 years and two months. Its registered office is in Thiruvananthapuram, Kerala, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.52 M.
The company currently has active open charges totaling ₹0.65 M. The company has closed loans amounting to ₹0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Kalikurup Chandrakumar and Chandra Kumari serve as directors at the Company.
Company Details
-
Location
Thiruvananthapuram, Kerala, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231KL1999PTC013499
-
Company No.
013499
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Dec 1999
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Nova Millennium Pharma India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalikurup Chandrakumar
|
Director | 09-Sep-2013 | Current |
|
Chandra Kumari
|
Director | 09-Sep-2013 | Current |
Financial Performance of Nova Millennium Pharma India.
Nova Millennium Pharma India Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nova Millennium Pharma India?
In 2017, Nova Millennium Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.65 M
₹0.50 M
Charges Breakdown by Lending Institutions
- Punjab National Bank : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Dec 2006 | Punjab National Bank | ₹0.65 M | Open |
| 20 Jun 2003 | Canara Bank | ₹0.50 M | Satisfied |
How Many Employees Work at Nova Millennium Pharma India?
Unlock and access historical data on people associated with Nova Millennium Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nova Millennium Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nova Millennium Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
